APA (7th ed.) Citation

Boudry, A., Goursaud, L., Lebon, D., Dumezy, F., Harrivel, V., Boue‐Raguet, A., . . . Duployez, N. (2025). Monitoring of measurable residual disease by next‐generation sequencing in patients with acute myeloid leukaemia. British Journal of Haematology, 207(5), 1953. https://doi.org/10.1111/bjh.70135

Chicago Style (17th ed.) Citation

Boudry, Augustin, et al. "Monitoring of Measurable Residual Disease by Next‐generation Sequencing in Patients with Acute Myeloid Leukaemia." British Journal of Haematology 207, no. 5 (2025): 1953. https://doi.org/10.1111/bjh.70135.

MLA (9th ed.) Citation

Boudry, Augustin, et al. "Monitoring of Measurable Residual Disease by Next‐generation Sequencing in Patients with Acute Myeloid Leukaemia." British Journal of Haematology, vol. 207, no. 5, 2025, p. 1953, https://doi.org/10.1111/bjh.70135.